$43.39 -0.22 (-0.50%) GlaxoSmithKline Shs Sponsored American Deposit Receipt Repr 2 Shs - New York Stock Exchange, Inc.

Aug. 30, 2016 | 02:34 PM
Last Trade: 43.39
Trade Time: Aug 30 02:34 PM Eastern Daylight Time
Change: -0.22 (-0.50%)
Prev Close: 43.61
Open: 43.44
Bid: 43.38
Ask: 43.39
  1. Alphabet-Glaxo Joint Venture Targets 'Bioelectronics'

    Investors Business Daily | Aug. 1, 2016 | 10:13AM EST
  2. Veeva Is Key Partner In Big Pharma's Race Against The Clock

    Investors Business Daily | Jul. 29, 2016 | 08:00AM EST
  3. Stock Futures Up, Gaining Strength; Apple Hauls Techs Higher

    Investors Business Daily | Jul. 27, 2016 | 08:00AM EST
  4. Lilly, J&J, Novo Battle For Diabetes Market Heats Up; FDA Rulings Loom

    Investors Business Daily | Jul. 22, 2016 | 10:44AM EST
  5. Getting to Know VBI Vaccines

    GuruFocus | Jul. 13, 2016 | 13:04PM EST
  6. Brandes Makes a Variety of Reductions in 4th Quarter

    GuruFocus | Feb. 11, 2016 | 18:19PM EST
  7. Stock Futures Up As Oil Behaves; Syngenta Up On ChemChina Deal

    IBD | Feb. 3, 2016 | 09:03AM EST
  8. EXCLUSIVE: Inovio Plans On Producing Zika Vaccine By Q3 2016, Ready For Phase 1 Study By Q4

    Benzinga | Jan. 29, 2016 | 13:38PM EST
  9. Benzinga's M&A Chatter for Thursday January 28, 2015

    Benzinga | Jan. 28, 2016 | 23:27PM EST
  10. 10 Fund Managers Are Totally Wrong on GlaxoSmithKline

    GuruFocus | Jan. 26, 2016 | 14:59PM EST
  11. Stocks Bring High Dividend Yields to HOTCHKIS & WILEY

    GuruFocus | Jan. 14, 2016 | 12:05PM EST
  12. Dynavax Hepatitis B Vaccine Beats Glaxo's In Trial

    IBD | Jan. 7, 2016 | 15:40PM EST
  13. Dynavax Hepatitis B Vaccine Beats Glaxo's In Trial

    IBD | Jan. 7, 2016 | 14:51PM EST
  14. Jeff Auxier's Holdings Trading Below Peter Lynch Earnings Line

    GuruFocus | Jan. 4, 2016 | 17:46PM EST
  15. Cisco Systems, Microsoft and Intel Bring High Dividend Yields to First Eagle Investment

    GuruFocus | Jan. 4, 2016 | 14:02PM EST
Trading Center